Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 December 2021 | Story Nonsindiso Qwabe
Dr Bernard
Dr Eleanor Bernard heads the Centre for Teaching and Learning on the Qwaqwa Campus.

“I realised that our students are not regularly exposed to and immersed in an English first language environment. So, for two years, I created control groups and tested how to implement a film club to support their language learning as well as engage them. In the end, I created a framework that university language teachers can use, with very specific guidelines as to how to make it successful.”

For her PhD study in Higher Education Studies, Dr Eleanor Bernard created a play on traditional learning by implementing a film club as a way of enhancing the basic interpersonal communicative and English literacy skills of non-native speakers on the Qwaqwa Campus. Dr Bernard is the Assistant Director of the Centre for Teaching and Learning on the Qwaqwa Campus. She will be graduating with her PhD in Higher Education Studies during the December 2021 graduations. The title of her study is: Implementing a film club to enhance English second-language students’ basic interpersonal communicative and basic English literacy skills.

Building on her passion for language learning and acquisition, Dr Bernard wanted her study to be a fun and interesting way of enhancing the already existing General English language module by creating a space for exposure and social interaction. She did this by forming student groups that would regularly watch films and opened spaces for engagement as a way of focusing on the language development of the students.

“The highlight for me was sitting in a university lecture venue, while watching Tsotsi or Pitch Perfect with students, and seeing them interacting, laughing, and enjoying a usually very serious space. Also, the wonderful discussions they shared on Blackboard around elements such as lobola, or stereotypes. Lastly, seeing how by the end of the year, they would walk into my office and interact with me more confidently in English,” she said.

Language studies has been a part of her academic journey from her Honours qualification. She has an MA degree in Language Studies from the UFS. She said working on the Qwaqwa Campus with language and literacy modules, she loved the process of watching students blossom as they gained more confidence in using the English language. “I especially love receiving a student at the beginning of the year, who you can see struggling and almost battling through the content and the skills. And then to see the change by the end of the year, and how their confidence increased.”

‘No learning can take place without engaging students’
She said she hoped faculties would also see the value of focusing on the language development of students as a baseline for academic literacy skills development.

“No learning can take place without engaging students, and there are so many guidelines and practical ways to ensure this engagement, including in language learning. Student success is not just about performance or final marks, but also about students completing a year where they have interacted with others and learned to care for them, where they have been changed to want to impact societies and communities, and where they have acquired skills that they will use when they enter the world of work.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept